Marblegate Capital (MGTE) EBITDA (2024 - 2026)
Marblegate Capital's (MGTE) quarterly EBITDA came in at -$616000.0 in Q4 2025, down 156.31% YoY from $1.1 million in Q4 2024, and up 50.36% on a QoQ basis from -$1.2 million in Q3 2025.
Marblegate Capital (MGTE) EBITDA (2024 - 2026) Analysis & Trends
Marblegate Capital (MGTE) has 2 years of EBITDA data on file, last reported at -$616000.0 in Q4 2025.
- Quarterly EBITDA fell 156.31% year-over-year to -$616000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 61.18% YoY) and the FY2025 annual result came in at $809000.0, down 86.7% from the prior year.
- EBITDA improved to -$616000.0 in Q4 2025, from -$1.2 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $3.6 million in Q2 2025 to a low of -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | -194,528.00 |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | -112,227.00 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | -174,182.00 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | -1.47 Mn |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | -115,742.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -1.35 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -197,949.00 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | -1.62 Mn |
| 10 | Marblegate Capital | 87.22 Mn | 180.32 Mn | - | -4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.30 Mn |
| Dec 31, 2025 | -616,000.00 |
| Sep 30, 2025 | -1.24 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | -91,619.00 |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.20 Mn |